Business

FDA approves Daybue - the first treatment for Rett syndrome

FDA approves Daybue - the first treatment for Rett syndrome

articleNeuren Pharmaceuticals LimitedMarch 12, 20233/company/neuren-pharmaceuticals-ltd/news/fda-approves-daybue-the-first-treatment-for-rett-syndrome
FDA approves Daybue - the first treatment for Rett syndrome

About this update from Neuren Pharmaceuticals Limited

[{"type":"text","content":"Neuren Pharmaceuticals Ltd has released a press release. View Attachment","length":254,"tagName":"div"}]

More updates from Neuren Pharmaceuticals Limited